Startup Data Analysis Firm SolveBio Bags $2M | GenomeWeb

NEW YORK (GenomeWeb) – Startup genomic data analysis firm SolveBio has raised $2 million that it intends to use to hire additional personnel.

The round was led by venture capital firm Andreessen Horowitz. Angel investment firm SV Angel, and individuals Nat Turner, Zach Weinberg, Max Levchin, and Charlie Cheever also participated in the round. In an email to GenomeWeb Daily News, SolveBio Co-Founder and CEO Mark Kaganovich said the funds will be used to hire engineers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.